Jazz Pharmaceuticals (JAZZ) was upgraded to a 'Buy' recommendation by TheStreet.com's quantitative service today. Let's check out the price charts and technical indicators to see if they are in agreement.
More from Investing
The big question now is whether the selling over the new variant was severe enough to produce some bounce action next week?
My view is to eat some leftovers, let the rest of the day play out, and come in fresh on Monday.
Because things are changing in the world, make sure your portfolio is protected with real returns.
When traders start to look harder for those names that are being sold without justification, that's the time to be more aggressive.